Ann Lab Med 2018; 38(3): 226-234
Comparison of Enterococcus faecium Bacteremic Isolates from Hematologic and Non-hematologic Patients: Differences in Antimicrobial Resistance and Molecular Characteristics
Sung-Yeon Cho, M.D.1,4,5, Yeon-Joon Park, M.D.2, Hanwool Cho, M.D.2, Dong Jin Park, M.D.2, Jin Kyung Yu, M.S.2, Hayeon Caitlyn Oak3, and Dong-Gun Lee, M.D.1,4,5
Division of Infectious Diseases1, Department of Internal Medicine and Department of Laboratory Medicine2, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Department of Brain and Cognitive Science3, Massachusetts Institute of Technology, Massachusetts, United States of America; Vaccine Bio Research Institute4 and Catholic Blood and Marrow Transplantation Center5, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Corresponding author: Yeon-Joon Park
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea
Tel: +82-2-2258-1640
Fax: +82-2-2258-1719
Received: April 29, 2017; Revised: July 25, 2017; Accepted: November 30, 2017; Published online: May 1, 2018.
© Korean Society for Laboratory Medicine. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Enterococcus faecium, especially vancomycin-resistant E. faecium (VREfm), is a major concern for patients with hematologic diseases. Exposure to antibiotics including fluoroquinolone, which is used as a routine prophylaxis for patients with hematologic (MH) diseases, has been reported to be a risk factor for infection with vancomycin-resistant eneterocci. We compared the characteristics of E. faecium isolates according to their vancomycin susceptibility and patient group (MH vs non-MH patients).
Methods: A total of 120 E. faecium bacteremic isolates (84 from MH and 36 from non-MH patients) were collected consecutively, and their characteristics (susceptibility, multilocus sequence type [MLST], Tn1546 type, and the presence of virulence genes and plasmids) were determined.
Results: Among the vancomycin-susceptible E. faecium (VSEfm) isolates, resistance to ampicillin (97.6% vs 61.1%) and high-level gentamicin (71.4% vs 38.9%) was significantly higher in isolates from MH patients than in those from non-MH patients. Notably, hyl, esp, and pEF1071 were present only in isolates with ampicillin resistance. Among the VREfm isolates, ST230 (33.3%) and ST17 (26.2%) were predominant in MH patients, while ST17 (61.1%) was predominant in non-MH patients. Plasmid pLG1 was more prevalent in E. faecium isolates from MH patients than in those from non-MH patients, regardless of vancomycin resistance. Transposon analysis revealed five types across all VREfm isolates.
Conclusions: The antimicrobial resistance profiles and molecular characteristics of E. faecium isolates differed according to the underlying diseases of patients within the same hospital. We hypothesize that the prophylactic use of fluoroquinolone might have an effect on these differences.
Keywords: Ampicillin, Fluoroquinolone, Enterococcus, Multilocus sequence typing, pEF1071, pLG1, ST230

This Article



Indexed/Covered by